Cite
MLA Citation
Shien Chow et al.. “High-dose interleukin-2 (hd-IL2) in treatment-naïve metastatic renal cell carcinoma (mrcc) - a 10 year single-site experience and outcome of prospective pathology-based patient selection.” Journal for immunotherapy of cancer, vol. 2, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100137793564.0x000006